Corvus Pharmaceuticals (CRVS) Other Accumulated Expenses (2015 - 2026)
Corvus Pharmaceuticals (CRVS) posted Other Accumulated Expenses of $299,000 for Q2 2026, down 13.6% from $346,000 a year earlier but up 45.1% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Other Accumulated Expenses (2015 - 2026) Analysis & Trends
At the end of FY2025, Corvus Pharmaceuticals' Other Accumulated Expenses came in at $238,000, down 17.6% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 5.7% (FY2020 to FY2025).
- In prior years, Corvus Pharmaceuticals' Other Accumulated Expenses was $289,000 in FY2024 (+18.0%), $245,000 in FY2023 (+55.1%), $158,000 in FY2022 (+30.6%) and $121,000 in FY2021 (-32.8%).
- Quarterly Other Accumulated Expenses has run from a low of $121,000 in Q4 2021 to a high of $566,000 in Q3 2025 over five years.
- On a year-over-year basis, Other Accumulated Expenses has declined in each of the last three quarters, with growth averaging 20.8% over the last eight quarters.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q1 2023, with growth of 85.8%; the weakest was Q3 2021, with a decline of 86.6%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $206,000 (Q1 2026), $238,000 (Q4 2025) and $566,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Corvus Pharmaceuticals | 916.92 Mn | 405.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 299,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 238,000.00 |
| Sep 30, 2025 | 566,000.00 |
| Jun 30, 2025 | 346,000.00 |
| Mar 31, 2025 | 296,000.00 |
| Dec 31, 2024 | 289,000.00 |
| Sep 30, 2024 | 402,000.00 |
| Jun 30, 2024 | 230,000.00 |
| Mar 31, 2024 | 179,000.00 |
| Dec 31, 2023 | 245,000.00 |
| Sep 30, 2023 | 262,000.00 |
| Jun 30, 2023 | 137,000.00 |
| Mar 31, 2023 | 379,000.00 |
| Dec 31, 2022 | 158,000.00 |
| Sep 30, 2022 | 176,000.00 |
| Jun 30, 2022 | 131,000.00 |
| Mar 31, 2022 | 204,000.00 |
| Dec 31, 2021 | 121,000.00 |
| Sep 30, 2021 | 130,000.00 |
API Access
Corvus Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();